Cargando…

c-Met expression in renal cell carcinoma with bone metastases

Hepatocyte growth factor (HGF)/c-Met pathway is implicated in embryogenesis and organ development and differentiation. Germline or somatic mutations, chromosomal rearrangements, gene amplification, and transcriptional upregulation in MET or alterations in autocrine or paracrine c-Met signalling have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva Paiva, Rita, Gomes, Inês, Casimiro, Sandra, Fernandes, Isabel, Costa, Luís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527574/ https://www.ncbi.nlm.nih.gov/pubmed/33024658 http://dx.doi.org/10.1016/j.jbo.2020.100315

Ejemplares similares

A Tailored Approach for Appendicular Impending and Pathologic Fractures in Solid Cancer Metastases
por: Soares do Brito, Joaquim, et al.
Publicado: (2022)

Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases
por: Whang, Young Mi, et al.
Publicado: (2019)

MET Expression in Sporadic Renal Cell Carcinomas
por: Choi, Jong Sun, et al.
Publicado: (2006)

The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases
por: Ferreira, Arlindo, et al.
Publicado: (2016)

Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
por: Mansinho, André, et al.
Publicado: (2019)

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
por: Lobo-Martins, Soraia, et al.
Publicado: (2020)

Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis
por: Mukai, Shoichiro, et al.
Publicado: (2014)

Renal Cell Carcinoma Metastasized to Pagetic Bone
por: Ramirez, Ashley, et al.
Publicado: (2016)

Osteoblastic bone metastases from renal cell carcinoma
por: Salapura, Vladka, et al.
Publicado: (2014)

Renal cell carcinoma metastasizing to the myeloproliferative bone marrow
por: Oo, Thein Hlaing, et al.
Publicado: (2018)

Expression of c-met gene in invasive ductal carcinomas
por: Park, CH, et al.
Publicado: (2005)

Clinicopathological impacts of high c-Met expression in renal cell carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Renal Cell Carcinoma with bone metastases isn’t always bad
por: Ruatta, Fiorella, et al.
Publicado: (2019)

Complete Remission of Bone Metastases in Renal Cell Carcinoma with Nivolumab
por: Vuyyala, Sowjanya, et al.
Publicado: (2019)

Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
por: Demkova, Lucia, et al.
Publicado: (2018)

The Roadmap of RANKL/RANK Pathway in Cancer
por: Casimiro, Sandra, et al.
Publicado: (2021)

The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer
por: Gomes, Inês, et al.
Publicado: (2023)

Serum sclerostin levels in renal cell carcinoma patients with bone metastases
por: Wibmer, C., et al.
Publicado: (2016)

An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2018)

Clinical Characteristics and Prognosis of Renal Cell Carcinoma With Spinal Bone Metastases
por: Zhai, Jianpo, et al.
Publicado: (2021)

C-met inhibition blocks bone metastasis development induced by renal cancer stem cells
por: D'Amico, Lucia, et al.
Publicado: (2016)

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors
por: Shuch, Brian, et al.
Publicado: (2015)

Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma
por: Wu, Ju-gang, et al.
Publicado: (2014)

The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012
por: Macedo, Daniela, et al.
Publicado: (2013)

MET Inhibition in Clear Cell Renal Cell Carcinoma
por: Xie, Zuoquan, et al.
Publicado: (2016)

Bone metastases in childhood renal tumours.
por: Marsden, H. B., et al.
Publicado: (1980)

Bone-metastasizing renal tumour of childhood.
por: Marsden, H. B., et al.
Publicado: (1978)

MET-04 A case of Brain Metastases with repeated bleeding from Esophageal carcinoma
por: Mikai, Masataka, et al.
Publicado: (2020)

ORP5 promotes tumor metastasis via stabilizing c-Met in renal cell carcinoma
por: Song, Li, et al.
Publicado: (2022)

Expression of c-MET in Invasive Meningioma
por: Yun, Sumi, et al.
Publicado: (2015)

Bone metastasis risk factors in breast cancer
por: Pulido, Catarina, et al.
Publicado: (2017)

Combination of the c-Met Inhibitor Tivantinib and Zoledronic Acid Prevents Tumor Bone Engraftment and Inhibits Progression of Established Bone Metastases in a Breast Xenograft Model
por: Previdi, Sara, et al.
Publicado: (2013)

A Review of Papillary Renal Cell Carcinoma and MET Inhibitors
por: Rhoades Smith, Katherine Emilie, et al.
Publicado: (2019)

Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
por: Xu, Yingying, et al.
Publicado: (2015)

Significance of PD-L1 clones and C-MET expression in hepatocellular carcinoma
por: Chun, Hyung-Wook, et al.
Publicado: (2019)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Bone metastases from renal cell carcinoma: patient survival after surgical treatment
por: Fottner, Andreas, et al.
Publicado: (2010)

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
por: Santoni, Matteo, et al.
Publicado: (2015)

All bone metastases are not created equal: Revisiting treatment resistance in renal cell carcinoma
por: Brozovich, Ava, et al.
Publicado: (2021)

Hormonal Treatment of Metastases of Renal Carcinoma
por: van der Werf-Messing, B., et al.
Publicado: (1971)

Cannot write session to /tmp/vufind_sessions/sess_2pmfur4siu6eotg3gs4fppejdt